当前位置: X-MOL 学术ACS Infect. Dis. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Structure-Based Analysis of Boronic Acids as Inhibitors of Acinetobacter-Derived Cephalosporinase-7, a Unique Class C β-Lactamase
ACS Infectious Diseases ( IF 5.3 ) Pub Date : 2017-11-16 00:00:00 , DOI: 10.1021/acsinfecdis.7b00152
Alexandra A. Bouza 1 , Hollister C. Swanson 1 , Kali A. Smolen 1 , Alison L. VanDine 1 , Magdalena A. Taracila 2, 3 , Chiara Romagnoli 4 , Emilia Caselli 4 , Fabio Prati 4 , Robert A. Bonomo 2, 3 , Rachel A. Powers 1 , Bradley J. Wallar 1
Affiliation  

Acinetobacter baumannii is a multidrug resistant pathogen that infects more than 12 000 patients each year in the US. Much of the resistance to β-lactam antibiotics in Acinetobacter spp. is mediated by class C β-lactamases known as Acinetobacter-derived cephalosporinases (ADCs). ADCs are unaffected by clinically used β-lactam-based β-lactamase inhibitors. In this study, five boronic acid transition state analog inhibitors (BATSIs) were evaluated for inhibition of the class C cephalosporinase ADC-7. Our goal was to explore the properties of BATSIs designed to probe the R1 binding site. Ki values ranged from low micromolar to subnanomolar, and circular dichroism (CD) demonstrated that each inhibitor stabilizes the β-lactamase–inhibitor complexes. Additionally, X-ray crystal structures of ADC-7 in complex with five inhibitors were determined (resolutions from 1.80 to 2.09 Å). In the ADC-7/CR192 complex, the BATSI with the lowest Ki (0.45 nM) and greatest ΔTm (+9 °C), a trifluoromethyl substituent, interacts with Arg340. Arg340 is unique to ADCs and may play an important role in the inhibition of ADC-7. The ADC-7/BATSI complexes determined in this study shed light into the unique recognition sites in ADC enzymes and also offer insight into further structure-based optimization of these inhibitors.

中文翻译:

硼酸作为不动杆菌衍生的头孢菌素酶-7(一种独特的C类β-内酰胺酶)抑制剂的基于结构的分析

鲍曼不动杆菌是一种耐多药病原体,在美国每年感染超过12000名患者。不动杆菌属中对β-内酰胺抗生素的大部分抗药性Cβ-内酰胺酶由称为不动杆菌的头孢菌素酶(ADC)的C类β-内酰胺酶介导。ADC不受临床使用的基于β-内酰胺的β-内酰胺酶抑制剂的影响。在这项研究中,评估了五种硼酸过渡态类似物抑制剂(BATSI)对C类头孢菌素酶ADC-7的抑制作用。我们的目标是探索旨在探测R1结合位点的BATSI的特性。ķ值范围从低微摩尔到亚纳摩尔,圆二色性(CD)证明每种抑制剂都能稳定β-内酰胺酶-抑制剂复合物。另外,测定了与五种抑制剂复合的ADC-7的X射线晶体结构(分辨率为1.80至2.09Å)。在ADC-7 / CR192复合物中,具有最低K i(0.45 nM)和最大ΔT m(+9°C)(三氟甲基取代基)的BATSI与Arg340相互作用。Arg340是ADC特有的,可能在抑制ADC-7中起重要作用。在这项研究中确定的ADC-7 / BATSI复合物揭示了ADC酶中独特的识别位点,也为深入了解这些抑制剂的基于结构的优化提供了见识。
更新日期:2017-11-16
down
wechat
bug